PFIZER INC Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax
PFIZER INC (PFE) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax of $6.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax · last filed 2026-08-04
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for the quarter ending 2026-06-28 was $6.00M, a 82.86% decline year-over-year.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for the quarter ending 2026-03-29 was $12.00M, a 81.25% decline year-over-year.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for the quarter ending 2025-12-31 was $33.00M.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for the quarter ending 2025-09-28 was $21.00M, a 27.59% decline year-over-year.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for fiscal 2025 was $152.00M.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for fiscal 2024 was -$84.00M, a 153.50% decline from fiscal 2023.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for fiscal 2023 was $157.00M, a 5.42% decline from fiscal 2022.
- PFIZER INC other comprehensive (income) loss, defined benefit plan, prior service cost (credit), after reclassification adjustment, before tax for fiscal 2022 was $166.00M, a 46.90% increase from fiscal 2021.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Reclassification Adjustment, before Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-28 | $6.00M 10-Q · filed 2026-08-04 | $18.00M 10-Q · filed 2026-08-04 | $51.00M derived: sum of 3 quarters · filed 2026-08-04 | $72.00M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-29 | $12.00M 10-Q · filed 2026-05-05 | $45.00M derived: sum of 2 quarters · filed 2026-05-05 | $66.00M derived: sum of 3 quarters · filed 2026-05-05 | $101.00M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $54.00M derived: sum of 2 quarters · filed 2026-02-26 | $89.00M derived: sum of 3 quarters · filed 2026-08-04 | $152.00M 10-K · filed 2026-02-26 | |
| 2025-09-28 | $21.00M 10-Q · filed 2025-11-04 | $56.00M derived: sum of 2 quarters · filed 2026-08-04 | $119.00M 10-Q · filed 2025-11-04 | -$49.00M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-29 | $35.00M 10-Q · filed 2026-08-04 | $99.00M 10-Q · filed 2026-08-04 | -$70.00M derived: sum of 3 quarters · filed 2026-08-04 | -$41.00M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-30 | $64.00M 10-Q · filed 2026-05-05 | -$105.00M derived: sum of 2 quarters · filed 2026-05-05 | -$76.00M derived: sum of 3 quarters · filed 2026-05-05 | -$48.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$169.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$140.00M derived: sum of 2 quarters · filed 2026-02-26 | -$112.00M derived: sum of 3 quarters · filed 2026-02-26 | -$84.00M 10-K · filed 2026-02-26 | |
| 2024-09-29 | $29.00M 10-Q · filed 2025-11-04 | $57.00M derived: sum of 2 quarters · filed 2025-11-04 | $85.00M 10-Q · filed 2025-11-04 | $140.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $28.00M 10-Q · filed 2025-08-05 | $56.00M 10-Q · filed 2025-08-05 | $111.00M derived: sum of 3 quarters · filed 2026-02-26 | $141.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $28.00M 10-Q · filed 2025-05-05 | $83.00M derived: sum of 2 quarters · filed 2026-02-26 | $113.00M derived: sum of 3 quarters · filed 2026-02-26 | $150.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $85.00M derived: sum of 2 quarters · filed 2026-02-26 | $122.00M derived: sum of 3 quarters · filed 2026-02-26 | $157.00M 10-K · filed 2026-02-26 | |
| 2023-10-01 | $30.00M 10-Q · filed 2024-11-04 | $67.00M derived: sum of 2 quarters · filed 2024-11-04 | $102.00M 10-Q · filed 2024-11-04 | $161.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-07-02 | $37.00M 10-Q · filed 2024-08-05 | $72.00M 10-Q · filed 2024-08-05 | $131.00M derived: sum of 3 quarters · filed 2025-02-27 | $160.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-04-02 | $35.00M 10-Q · filed 2024-05-08 | $94.00M derived: sum of 2 quarters · filed 2025-02-27 | $123.00M derived: sum of 3 quarters · filed 2025-02-27 | $153.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $88.00M derived: sum of 2 quarters · filed 2025-02-27 | $118.00M derived: sum of 3 quarters · filed 2025-02-27 | $166.00M 10-K · filed 2025-02-27 | |
| 2022-10-02 | $29.00M 10-Q · filed 2023-11-08 | $59.00M derived: sum of 2 quarters · filed 2023-11-08 | $107.00M 10-Q · filed 2023-11-08 | $38.00M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-07-03 | $30.00M 10-Q · filed 2023-08-09 | $78.00M 10-Q · filed 2023-08-09 | $9.00M derived: sum of 3 quarters · filed 2024-02-22 | $106.00M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-04-03 | $47.00M 10-Q · filed 2023-05-10 | -$21.00M derived: sum of 2 quarters · filed 2024-02-22 | $76.00M derived: sum of 3 quarters · filed 2024-02-22 | $117.00M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | -$68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $29.00M derived: sum of 2 quarters · filed 2024-02-22 | $70.00M derived: sum of 3 quarters · filed 2024-02-22 | $113.00M 10-K · filed 2024-02-22 | |
| 2021-10-03 | $97.00M 10-Q · filed 2022-11-09 | $138.00M derived: sum of 2 quarters · filed 2022-11-09 | $181.00M 10-Q · filed 2022-11-09 | $172.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-07-04 | $41.00M 10-Q · filed 2022-08-10 | $84.00M 10-Q · filed 2022-08-10 | $75.00M derived: sum of 3 quarters · filed 2023-02-23 | $122.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-04-04 | $43.00M 10-Q · filed 2022-05-11 | $34.00M derived: sum of 2 quarters · filed 2023-02-23 | $81.00M derived: sum of 3 quarters · filed 2023-02-23 | $121.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $38.00M derived: sum of 2 quarters · filed 2023-02-23 | $78.00M derived: sum of 3 quarters · filed 2023-02-23 | $124.00M 10-K · filed 2023-02-23 | |
| 2020-09-27 | $47.00M 10-Q · filed 2021-11-12 | $87.00M derived: sum of 2 quarters · filed 2021-11-12 | $133.00M 10-Q · filed 2021-11-12 | $141.00M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-28 | $40.00M 10-Q · filed 2021-08-12 | $85.00M 10-Q · filed 2021-08-12 | $94.00M derived: sum of 3 quarters · filed 2022-02-24 | $182.00M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-29 | $45.00M 10-Q · filed 2021-05-13 | $54.00M derived: sum of 2 quarters · filed 2022-02-24 | $142.00M derived: sum of 3 quarters · filed 2022-02-24 | $188.00M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $97.00M derived: sum of 2 quarters · filed 2022-02-24 | $143.00M derived: sum of 3 quarters · filed 2022-02-24 | $189.00M 10-K · filed 2022-02-24 | |
| 2019-09-29 | $88.00M 10-Q · filed 2020-11-05 | $134.00M derived: sum of 2 quarters · filed 2020-11-05 | $180.00M 10-Q · filed 2020-11-05 | $233.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $46.00M 10-Q · filed 2020-08-06 | $92.00M 10-Q · filed 2020-08-06 | $145.00M derived: sum of 3 quarters · filed 2021-02-25 | $195.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $46.00M 10-Q · filed 2020-05-07 | $99.00M derived: sum of 2 quarters · filed 2021-02-25 | $149.00M derived: sum of 3 quarters · filed 2021-02-25 | $202.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $103.00M derived: sum of 2 quarters · filed 2021-02-25 | $156.00M derived: sum of 3 quarters · filed 2021-02-25 | $207.00M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $50.00M 10-Q · filed 2019-11-07 | $103.00M derived: sum of 2 quarters · filed 2019-11-07 | $154.00M 10-Q · filed 2019-11-07 | $206.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-07-01 | $53.00M 10-Q · filed 2019-08-08 | $104.00M 10-Q · filed 2019-08-08 | $156.00M derived: sum of 3 quarters · filed 2020-02-27 | $204.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-04-01 | $51.00M 10-Q · filed 2019-05-09 | $103.00M derived: sum of 2 quarters · filed 2020-02-27 | $151.00M derived: sum of 3 quarters · filed 2020-02-27 | $203.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $100.00M derived: sum of 2 quarters · filed 2020-02-27 | $152.00M derived: sum of 3 quarters · filed 2020-02-27 | $203.00M 10-K · filed 2020-02-27 | |
| 2017-10-01 | $48.00M 10-Q · filed 2018-11-08 | $100.00M derived: sum of 2 quarters · filed 2018-11-08 | $151.00M 10-Q · filed 2018-11-08 | $214.00M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-07-02 | $52.00M 10-Q · filed 2018-08-09 | $104.00M 10-Q · filed 2018-08-09 | $166.00M derived: sum of 3 quarters · filed 2019-02-28 | $118.00M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-04-02 | $52.00M 10-Q · filed 2018-05-10 | $114.00M derived: sum of 2 quarters · filed 2019-02-28 | $66.00M derived: sum of 3 quarters · filed 2019-02-28 | $18.00M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $14.00M derived: sum of 2 quarters · filed 2019-02-28 | -$34.00M derived: sum of 3 quarters · filed 2019-02-28 | $8.00M 10-K · filed 2019-02-28 | |
| 2016-10-02 | -$48.00M 10-Q · filed 2017-11-09 | -$96.00M derived: sum of 2 quarters · filed 2017-11-09 | -$54.00M 10-Q · filed 2017-11-09 | $75.00M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-07-03 | -$48.00M 10-Q · filed 2017-08-10 | -$6.00M 10-Q · filed 2017-08-10 | $123.00M derived: sum of 3 quarters · filed 2018-02-22 | $174.00M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-04-03 | $42.00M 10-Q · filed 2017-05-11 | $171.00M derived: sum of 2 quarters · filed 2018-02-22 | $222.00M derived: sum of 3 quarters · filed 2018-02-22 | -$242.00M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2015-12-31 | $129.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $180.00M derived: sum of 2 quarters · filed 2018-02-22 | -$284.00M derived: sum of 3 quarters · filed 2018-02-22 | -$237.00M 10-K · filed 2018-02-22 | |
| 2015-09-27 | $51.00M 10-Q · filed 2016-11-10 | -$413.00M derived: sum of 2 quarters · filed 2016-11-10 | -$366.00M 10-Q · filed 2016-11-10 | -$1.08B derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-06-28 | -$464.00M 10-Q · filed 2016-08-11 | -$418.00M 10-Q · filed 2016-08-11 | -$1.13B derived: sum of 3 quarters · filed 2017-02-23 | -$1.12B derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-03-29 | $46.00M 10-Q · filed 2016-05-12 | -$670.00M derived: sum of 2 quarters · filed 2017-02-23 | -$652.00M derived: sum of 3 quarters · filed 2017-02-23 | -$649.00M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2014-12-31 | -$716.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$698.00M derived: sum of 2 quarters · filed 2017-02-23 | -$695.00M derived: sum of 3 quarters · filed 2017-02-23 | -$672.00M 10-K · filed 2017-02-23 | |
| 2014-09-28 | $18.00M 10-Q · filed 2015-11-05 | $21.00M derived: sum of 2 quarters · filed 2015-11-05 | $44.00M 10-Q · filed 2015-11-05 | -$97.00M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-29 | $3.00M 10-Q · filed 2015-08-06 | $26.00M 10-Q · filed 2015-08-06 | -$115.00M derived: sum of 3 quarters · filed 2016-02-29 | -$101.00M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-30 | $23.00M 10-Q · filed 2015-05-07 | -$118.00M derived: sum of 2 quarters · filed 2016-02-29 | -$104.00M derived: sum of 3 quarters · filed 2016-02-29 | -$87.00M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$141.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$127.00M derived: sum of 2 quarters · filed 2016-02-29 | -$110.00M derived: sum of 3 quarters · filed 2016-02-29 | -$86.00M 10-K · filed 2016-02-29 | |
| 2013-09-29 | $14.00M 10-Q · filed 2014-11-06 | $31.00M derived: sum of 2 quarters · filed 2014-11-06 | $55.00M 10-Q · filed 2014-11-06 | $116.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | $17.00M 10-Q · filed 2014-08-07 | $41.00M 10-Q · filed 2014-08-07 | $102.00M derived: sum of 3 quarters · filed 2015-02-27 | $124.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | $24.00M 10-Q · filed 2014-05-08 | $85.00M derived: sum of 2 quarters · filed 2015-02-27 | $107.00M derived: sum of 3 quarters · filed 2015-02-27 | $171.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $83.00M derived: sum of 2 quarters · filed 2015-02-27 | $147.00M derived: sum of 3 quarters · filed 2015-02-27 | $177.00M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $22.00M 10-Q · filed 2013-11-08 | $86.00M derived: sum of 2 quarters · filed 2013-11-08 | $116.00M 10-Q · filed 2013-11-08 | $63.00M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-07-01 | $64.00M 10-Q · filed 2013-08-09 | $94.00M 10-Q · filed 2013-08-09 | $41.00M derived: sum of 3 quarters · filed 2014-02-28 | $74.00M derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-04-01 | $30.00M 10-Q · filed 2013-05-10 | -$30.00M 10-Q · filed 2012-05-10 | -$23.00M derived: sum of 2 quarters · filed 2014-02-28 | $10.00M derived: sum of 3 quarters · filed 2014-02-28 | $50.00M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | -$53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$20.00M derived: sum of 2 quarters · filed 2014-02-28 | $20.00M derived: sum of 3 quarters · filed 2014-02-28 | $51.00M 10-K · filed 2014-02-28 | |
| 2011-10-02 | $33.00M 10-Q · filed 2012-11-09 | $73.00M derived: sum of 2 quarters · filed 2012-11-09 | $104.00M 10-Q · filed 2012-11-09 | ||
| 2011-07-03 | $40.00M 10-Q · filed 2012-08-09 | $71.00M 10-Q · filed 2012-08-09 | |||
| 2011-04-03 | -$31.00M 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | -$464.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |